You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 5, 2024

Eugia Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?

EUGIA PHARMA has one hundred and sixty-seven approved drugs.

There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.

There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and thirty-one supplementary protection certificates in eighteen countries.

Summary for Eugia Pharma
International Patents:10
US Patents:1
Tradenames:141
Ingredients:133
NDAs:167
Patent Litigation for Eugia Pharma: See patent lawsuits for Eugia Pharma

Drugs and US Patents for Eugia Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma MITOMYCIN mitomycin INJECTABLE;INJECTION 216732-003 Oct 30, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma FONDAPARINUX SODIUM fondaparinux sodium INJECTABLE;SUBCUTANEOUS 206918-002 Dec 26, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 205779-001 Mar 29, 2016 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma PLERIXAFOR plerixafor SOLUTION;SUBCUTANEOUS 213672-001 Jul 24, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma ADENOSINE adenosine SOLUTION;INTRAVENOUS 205331-001 Nov 2, 2017 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 205982-002 Oct 9, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Eugia Pharma Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2435024 LUC00208 Luxembourg ⤷  Try a Trial PRODUCT NAME: COMBINAISON DE FORMOTEROL (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), DE GLYCOPYRRONIUM (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET DE BUDESONIDE (Y COMPRIS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1468 20201210
0138504 SPC/GB04/009 United Kingdom ⤷  Try a Trial PRODUCT NAME: FULVESTRANT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: UK EU/1/03/269/001 20040310
0799044 02C0040 France ⤷  Try a Trial PRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517
2371361 132020000000007 Italy ⤷  Try a Trial PRODUCT NAME: PLERIXAFOR OPZIONALMENTE IN FORMA DI UN SUO SALE FARMACEUTICAMENTE ACCETTABILE O UN SUO COMPLESSO METALLICO(MOZOBIL); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/09/537/001, 20090804
2782584 132021000000197 Italy ⤷  Try a Trial PRODUCT NAME: ESTRADIOLO (17SS-ESTRADIOLO) IN PARTICOLARE NELLA FORMA EMIIDRATA, E PROGESTERONE COMPRENDENTI LE VARIE FORME DI ESTRADIOLO (17SS-ESTRADIOLO), QUALI LE FORME IDRATE E SOLVATATE, INCLUDENDO LA FORMA EMIIDRATA, ED I SUOI SALI.(BIJUVA); AUTHORISATION NUMBER(S) AND DATE(S): BE582231, 20210406;048335018 -048335020, 20210517
0619813 SPC/GB10/004 United Kingdom ⤷  Try a Trial PRODUCT NAME: PLERIXAFOR IN ALL FORMS PROTECTED BY THE BASIC PATENT; REGISTERED: UK EU/1/09/537/001 20090731; REASON FOR LAPSE: SURRENDERED
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.